IN2014DN10706A - - Google Patents

Info

Publication number
IN2014DN10706A
IN2014DN10706A IN10706DEN2014A IN2014DN10706A IN 2014DN10706 A IN2014DN10706 A IN 2014DN10706A IN 10706DEN2014 A IN10706DEN2014 A IN 10706DEN2014A IN 2014DN10706 A IN2014DN10706 A IN 2014DN10706A
Authority
IN
India
Prior art keywords
skin patch
improved
drug
adhesive strength
organic solvent
Prior art date
Application number
Other languages
English (en)
Inventor
Hidetoshi Hamamoto
Katsuhiro Yamanaka
Takahiro Tanimoto
Original Assignee
Medrx Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49768781&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN10706(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medrx Co Ltd filed Critical Medrx Co Ltd
Publication of IN2014DN10706A publication Critical patent/IN2014DN10706A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/23Calcitonins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN10706DEN2014 2012-06-20 2013-06-18 IN2014DN10706A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012139215 2012-06-20
PCT/JP2013/066765 WO2013191187A1 (ja) 2012-06-20 2013-06-18 薬剤と有機溶媒と親油性膏体基剤と粉体を配合した貼付製剤組成物

Publications (1)

Publication Number Publication Date
IN2014DN10706A true IN2014DN10706A (enExample) 2015-09-04

Family

ID=49768781

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10706DEN2014 IN2014DN10706A (enExample) 2012-06-20 2013-06-18

Country Status (16)

Country Link
US (2) US10543275B2 (enExample)
EP (1) EP2865376B2 (enExample)
JP (1) JP6309892B2 (enExample)
CN (3) CN110693859A (enExample)
AU (1) AU2013278403B2 (enExample)
BR (1) BR112014031701A2 (enExample)
CA (1) CA2875454C (enExample)
DK (1) DK2865376T4 (enExample)
ES (1) ES2738303T5 (enExample)
HU (1) HUE045479T2 (enExample)
IN (1) IN2014DN10706A (enExample)
PL (1) PL2865376T5 (enExample)
PT (1) PT2865376T (enExample)
SI (1) SI2865376T1 (enExample)
TR (1) TR201911328T4 (enExample)
WO (1) WO2013191187A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3824883B1 (en) * 2013-09-11 2023-08-02 MEDRx Co., Ltd. Novel composition for plaster base material in tape preparation
CN103830206B (zh) * 2014-02-26 2016-08-31 上海现代药物制剂工程研究中心有限公司 阿戈美拉汀三维网状立体构型的透皮给药制剂及制备方法
US10045948B2 (en) 2014-02-27 2018-08-14 Medrx Co., Ltd. Pramipexole-containing transdermal patch for treatment of neurodegenerative disease
WO2016109483A1 (en) * 2014-12-30 2016-07-07 Noven Pharmaceuticals, Inc. Transdermal drug delivery systems for agomelatine
US10016502B2 (en) 2015-08-29 2018-07-10 Medrx Co., Ltd Patch preparation containing an acid scavenger
WO2017037812A1 (ja) * 2015-08-29 2017-03-09 株式会社メドレックス 酸捕捉剤を含有する貼付製剤
CN107427509B (zh) * 2015-08-29 2021-06-15 美德阿利克斯株式会社 含有碱性药物和山梨酸的经皮吸收组成物
ES2957234T3 (es) * 2016-03-24 2024-01-15 Medrx Co Ltd Preparación de parche con características de prevención del uso incorrecto de sustancias
US20170273974A1 (en) 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
JP7143219B2 (ja) * 2016-11-09 2022-09-28 株式会社クラレ 粘着シート、絆創膏及びこれらの製造方法
CN113164423A (zh) * 2018-10-04 2021-07-23 美德阿利克斯株式会社 用非水溶剂稳定化的制剂
JPWO2022173006A1 (enExample) * 2021-02-12 2022-08-18
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3144895B2 (ja) 1992-06-30 2001-03-12 積水化学工業株式会社 医療用粘着テープもしくはシート
JPH06145050A (ja) 1992-11-11 1994-05-24 Sekisui Chem Co Ltd 貼付剤の製造方法
JPH07145047A (ja) 1993-11-25 1995-06-06 Sekisui Chem Co Ltd 局所麻酔用経皮吸収テープ
JPH0827003A (ja) 1994-07-22 1996-01-30 Sekisui Chem Co Ltd 経皮吸収製剤
JPH09169636A (ja) 1995-06-12 1997-06-30 Sekisui Chem Co Ltd 貼付剤
JPH09136834A (ja) 1995-11-14 1997-05-27 Sekisui Chem Co Ltd 経皮吸収貼付剤
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 4−ビフェニル酢酸含有貼付剤
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
US6503532B1 (en) * 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof
US7785622B2 (en) * 2002-09-13 2010-08-31 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch for fentanyl administration
JP4629578B2 (ja) * 2003-01-22 2011-02-09 ニチバン株式会社 眼疾患治療用経皮吸収型製剤
US8080261B2 (en) * 2004-09-30 2011-12-20 Teikoku Pharma Usa, Inc. 1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
WO2008032718A1 (en) * 2006-09-11 2008-03-20 Sekisui Chemical Co., Ltd. Adhesive preparation
ATE543490T1 (de) 2006-09-11 2012-02-15 Sekisui Chemical Co Ltd Klebende zubereitung mit desglymidodrin
US8623387B2 (en) * 2007-11-22 2014-01-07 Medrx Co., Ltd. External preparation composition comprising fatty acid-based ionic liquid as active ingredient
US20110189261A1 (en) 2008-03-03 2011-08-04 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP4822032B2 (ja) 2009-01-08 2011-11-24 タイヨーエレック株式会社 組合せ式遊技機
WO2010113225A1 (en) * 2009-03-30 2010-10-07 Yutoku Pharmaceutical Industries Co., Ltd. Riluzole-containing transdermal patch
DE102009022915A1 (de) * 2009-05-27 2010-12-09 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit gesteuertem Wirkstofffluss
JP2011074035A (ja) 2009-09-30 2011-04-14 Sekisui Medical Co Ltd 貼付剤

Also Published As

Publication number Publication date
SI2865376T1 (sl) 2019-11-29
US20190388544A1 (en) 2019-12-26
BR112014031701A2 (pt) 2017-06-27
EP2865376B1 (en) 2019-06-05
EP2865376A4 (en) 2015-11-18
CA2875454C (en) 2021-02-16
TR201911328T4 (tr) 2019-08-21
JP6309892B2 (ja) 2018-04-11
ES2738303T3 (es) 2020-01-21
DK2865376T3 (da) 2019-08-12
CA2875454A1 (en) 2013-12-27
WO2013191187A1 (ja) 2013-12-27
JPWO2013191187A1 (ja) 2016-05-26
HUE045479T2 (hu) 2019-12-30
PL2865376T5 (pl) 2023-01-09
US20150174249A1 (en) 2015-06-25
CN104363900A (zh) 2015-02-18
US10543275B2 (en) 2020-01-28
US12016924B2 (en) 2024-06-25
EP2865376A1 (en) 2015-04-29
AU2013278403A1 (en) 2015-01-22
PT2865376T (pt) 2019-08-26
CN110693859A (zh) 2020-01-17
ES2738303T5 (es) 2022-09-12
DK2865376T4 (da) 2022-07-18
EP2865376B2 (en) 2022-05-11
AU2013278403B2 (en) 2018-02-01
PL2865376T3 (pl) 2019-12-31
CN108553452A (zh) 2018-09-21

Similar Documents

Publication Publication Date Title
IN2014DN10706A (enExample)
MX2015013727A (es) Composicion para preparacion de uso externo con permeabilidad transdermica mejorada.
IN2015DN00544A (enExample)
WO2013142611A3 (en) Silk reservoirs for drug delivery
HUE044118T2 (hu) Hatóanyagként ektoint vagy hidroxiektoint tartalmazó készítmény sérült testszövetek regenerálódásának gyorsítására
IL233497A0 (en) A process for preparing an aqueous solution containing at least one trace alkali hydrogen carbonate and its use
HRP20160888T1 (hr) Postupak za pripremanje vodene otopine koja sadrži barem jedan zemnoalkalijski hidrogenkarbonat te njezina uporaba
EP3088426A4 (en) Compound containing mesogenic group, and mixture, composition, and optically anisotropic body using said compound
SG195086A1 (en) Compounds containing hydrido-tricyano-borate anions
IN2015DN01164A (enExample)
IN2015DN01165A (enExample)
UA109144C2 (ru) Дезинфицирующий и антисептический препарат с пониженным содержанием йода
FI20120287L (fi) Hartsihappoja sisältävä vesikoostumus käytettäväksi antimikrobisena hoitoaineena ja lisäaineena
IL235484A0 (en) Glucokinase-activating preparations for the treatment of diabetes
FI20110371L (fi) Veden pihkaseoskoostumus (dispersio) käytettäväksi antimikrobisena lääketieteellisenä hoitoaineena ja antimikrobisena lisäaineena vesiohenteisissa liuoksissa sekä teknillisissä materiaaleissa
HK1223852A1 (zh) 睪丸酮凝膠組合物及相關方法
WO2012063498A3 (ja) 新規なエキセメスタン固体分散体
AP2012006545A0 (en) Electrochemically activated waterbased solution and use of the solution
CL2014003282A1 (es) Uso de cetal como solvente en adhesivos y composición adhesiva que contiene cetal.
ZA201405920B (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
ZA201405302B (en) Process for the preparation of an aqueous solution comprising at least one earth alkali hydrogen carbonate and its use
AU2012901130A0 (en) A composition and method for enhancing the permeability of a tissue of a subject to an active agent
ZA201407279B (en) Aqueous compositions containing the potassium salt of (s)-(+)-abscisic acid